Powerlong Real Estate Holdings Valuation
Is 1238 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 1238 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von 1238 für die Bewertungsanalyse.
Deutlich unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von 1238 für die Bewertungsanalyse.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1238?
Other financial metrics that can be useful for relative valuation.
What is 1238's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥2.33b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.2x |
Enterprise Value/EBITDA | 176.2x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 1238's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.2x | ||
884 CIFI Holdings (Group) | 0.04x | -33.0% | HK$2.9b |
846 Mingfa Group (International) | 0.2x | n/a | HK$2.1b |
3377 Sino-Ocean Group Holding | 0.04x | -11.9% | HK$2.1b |
95 LVGEM (China) Real Estate Investment | 0.5x | 57.4% | HK$3.6b |
1238 Powerlong Real Estate Holdings | 0.1x | 1.3% | HK$2.5b |
Price-To-Sales gegen Gleichaltrige: 1238 ist ein guter Wert, wenn man sein Price-To-Sales Verhältnis (0.1x) mit dem Durchschnitt der anderen Unternehmen (0.1x) vergleicht.
Price to Earnings Ratio vs Industry
How does 1238's PE Ratio compare vs other companies in the HK Real Estate Industry?
Price-To-Sales gegen Industrie: 1238 ist aufgrund seines Price-To-Sales Verhältnisses (0.1x) im Vergleich zum Hong Kong Real Estate Branchendurchschnitt (0.6x) ein guter Wert.
Price to Sales Ratio vs Fair Ratio
What is 1238's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.1x |
Fair PS Ratio | 0.2x |
PM vs. Fair Ratio: 1238 ist ein guter Wert auf der Grundlage des Verhältnisses Price-To-Sales (0.1x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Sales (0.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | HK$0.60 | HK$0.85 +42.3% | 13.9% | HK$0.97 | HK$0.74 | n/a | 2 |
Mar ’25 | HK$0.64 | HK$0.85 +33.4% | 13.9% | HK$0.97 | HK$0.74 | n/a | 2 |
Feb ’25 | HK$0.62 | HK$0.85 +37.7% | 13.9% | HK$0.97 | HK$0.74 | n/a | 2 |
Jan ’25 | HK$0.73 | HK$0.85 +16.4% | 13.6% | HK$0.97 | HK$0.73 | n/a | 2 |
Dec ’24 | HK$0.71 | HK$0.96 +35.4% | 1.2% | HK$0.97 | HK$0.95 | n/a | 2 |
Nov ’24 | HK$0.76 | HK$0.96 +26.2% | 2.3% | HK$0.98 | HK$0.94 | n/a | 2 |
Oct ’24 | HK$0.94 | HK$0.90 -3.8% | 8.3% | HK$0.98 | HK$0.80 | n/a | 3 |
Sep ’24 | HK$0.84 | HK$1.74 +107.6% | 83.5% | HK$4.26 | HK$0.80 | n/a | 4 |
Aug ’24 | HK$1.02 | HK$1.77 +74.0% | 74.5% | HK$4.32 | HK$0.80 | n/a | 5 |
Jul ’24 | HK$0.93 | HK$1.89 +102.9% | 67.8% | HK$4.37 | HK$0.97 | n/a | 5 |
Jun ’24 | HK$0.89 | HK$1.89 +112.0% | 67.8% | HK$4.37 | HK$0.97 | n/a | 5 |
May ’24 | HK$1.22 | HK$2.20 +80.0% | 57.1% | HK$4.54 | HK$0.99 | n/a | 5 |
Apr ’24 | HK$1.36 | HK$2.72 +100.3% | 63.5% | HK$5.52 | HK$0.85 | HK$0.61 | 6 |
Mar ’24 | HK$1.70 | HK$2.72 +59.9% | 64.9% | HK$5.55 | HK$0.72 | HK$0.64 | 6 |
Feb ’24 | HK$1.75 | HK$3.67 +109.6% | 75.7% | HK$9.12 | HK$0.74 | HK$0.62 | 7 |
Jan ’24 | HK$1.57 | HK$3.24 +106.4% | 82.5% | HK$8.89 | HK$0.72 | HK$0.73 | 8 |
Dec ’23 | HK$1.25 | HK$2.98 +138.3% | 88.2% | HK$8.52 | HK$0.67 | HK$0.71 | 8 |
Nov ’23 | HK$0.69 | HK$3.29 +376.8% | 80.0% | HK$8.62 | HK$0.67 | HK$0.76 | 9 |
Oct ’23 | HK$0.80 | HK$3.34 +316.9% | 80.3% | HK$8.81 | HK$0.69 | HK$0.94 | 9 |
Sep ’23 | HK$1.02 | HK$3.48 +241.0% | 78.6% | HK$9.09 | HK$0.71 | HK$0.84 | 9 |
Aug ’23 | HK$1.02 | HK$4.24 +315.3% | 62.0% | HK$9.13 | HK$1.35 | HK$1.02 | 10 |
Jul ’23 | HK$1.31 | HK$4.81 +267.1% | 47.2% | HK$8.70 | HK$1.70 | HK$0.93 | 11 |
Jun ’23 | HK$2.08 | HK$4.99 +139.8% | 41.4% | HK$8.66 | HK$2.12 | HK$0.89 | 11 |
May ’23 | HK$2.70 | HK$5.33 +97.4% | 36.8% | HK$8.83 | HK$2.41 | HK$1.22 | 11 |
Apr ’23 | HK$2.18 | HK$6.00 +175.4% | 32.5% | HK$9.15 | HK$2.50 | HK$1.36 | 11 |
Analysten-Prognose: Das Kursziel liegt mehr als 20% über dem aktuellen Aktienkurs, aber es gibt nicht genügend Analysten, die die Aktie beobachten, um eine statistische Sicherheit für eine Übereinstimmung zu ermitteln.